Results 101 to 110 of about 416 (118)

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method

International Journal of Molecular Sciences, 2022
Rolf Teschke, Nahum Mendez-Sanchez
exaly  

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment

Metabolites, 2022
Marta Moreno-Torres, Guillermo QuintÁs, Jose V Castell   +2 more
exaly  

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

International Journal of Molecular Sciences, 2016
Fernando Bessone, Nelia Hernández, Mahmoud Slim   +2 more
exaly  

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Nature Reviews Drug Discovery, 2019
Richard J Weaver, Amy E Chadwick, Christopher E Goldring   +2 more
exaly  

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

Current Drug Metabolism, 2018
Lucija Kuna, Tomislav Kizivat, Kristina Bojanic   +2 more
exaly  

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Toxicology in Vitro, 2015
Stefan Kustermann, Kuresh Youdim
exaly  

Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

Clinical Gastroenterology and Hepatology, 2018
Inmaculada Medina-Caliz, Miren García Cortes, Andres Gonzalez-Jimenez   +2 more
exaly  

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019

Frontiers in Pharmacology, 2019
Rolf Teschke
exaly  

The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury

Expert Review of Gastroenterology and Hepatology, 2018
Shraddha Thakkar, Minjun Chen, Hong Fang
exaly  

Liver biopsy differentiates DILI from autoimmune hepatitis

Nature Reviews Gastroenterology and Hepatology, 2011
exaly